Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-01-08 2020-01-08
Drug Identification Number 02382849 02382849
Brand name GLYCOPYRROLATE INJECTION MULTIDOSE GLYCOPYRROLATE INJECTION MULTIDOSE
Common or Proper name Glycopyrrolate Injection Multidose Glycopyrrolate Injection Multidose
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients GLYCOPYRROLATE GLYCOPYRROLATE
Strength(s) 0.2MG 0.2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 1 x 20mL vial / fiole 1 x 20mL vial / fiole
ATC code A03AB A03AB
ATC description DRUGS FOR FUNCTIONAL BOWEL DISORDERS DRUGS FOR FUNCTIONAL BOWEL DISORDERS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-24 2019-10-24
Estimated end date 2019-12-31 2019-12-31
Actual end date 2020-01-03 2020-01-03
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments On allocation On allocation
Health Canada comments